Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
2000 1
2001 3
2003 1
2004 3
2005 2
2006 2
2007 2
2008 1
2009 1
2010 2
2011 3
2012 2
2013 5
2015 1
2016 3
2018 2
2019 2
2020 1
2021 2
2022 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Results by year

Filters applied: . Clear all
Page 1
Angiotensin-Neprilysin Inhibition in Acute Decompensated Heart Failure.
Velazquez EJ, Morrow DA, DeVore AD, Duffy CI, Ambrosy AP, McCague K, Rocha R, Braunwald E; PIONEER-HF Investigators. Velazquez EJ, et al. N Engl J Med. 2019 Feb 7;380(6):539-548. doi: 10.1056/NEJMoa1812851. Epub 2018 Nov 11. N Engl J Med. 2019. PMID: 30415601 Clinical Trial.
Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure.
Costanzo MR, Guglin ME, Saltzberg MT, Jessup ML, Bart BA, Teerlink JR, Jaski BE, Fang JC, Feller ED, Haas GJ, Anderson AS, Schollmeyer MP, Sobotka PA; UNLOAD Trial Investigators. Costanzo MR, et al. Among authors: saltzberg mt. J Am Coll Cardiol. 2007 Feb 13;49(6):675-83. doi: 10.1016/j.jacc.2006.07.073. Epub 2007 Jan 26. J Am Coll Cardiol. 2007. PMID: 17291932 Free article. Clinical Trial.
Effect of levosimendan on the short-term clinical course of patients with acutely decompensated heart failure.
Packer M, Colucci W, Fisher L, Massie BM, Teerlink JR, Young J, Padley RJ, Thakkar R, Delgado-Herrera L, Salon J, Garratt C, Huang B, Sarapohja T; REVIVE Heart Failure Study Group. Packer M, et al. JACC Heart Fail. 2013 Apr;1(2):103-11. doi: 10.1016/j.jchf.2012.12.004. Epub 2013 Apr 1. JACC Heart Fail. 2013. PMID: 24621834 Free article. Clinical Trial.
Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial.
Verma S, Dhingra NK, Butler J, Anker SD, Ferreira JP, Filippatos G, Januzzi JL, Lam CSP, Sattar N, Peil B, Nordaby M, Brueckmann M, Pocock SJ, Zannad F, Packer M; EMPEROR-Reduced trial committees and investigators. Verma S, et al. Lancet Diabetes Endocrinol. 2022 Jan;10(1):35-45. doi: 10.1016/S2213-8587(21)00292-8. Epub 2021 Nov 30. Lancet Diabetes Endocrinol. 2022. PMID: 34861154
Destination mechanical circulatory support: proposal for clinical standards.
Deng MC, Young JB, Stevenson LW, Oz MC, Rose EA, Hunt SA, Kirklin JK, Kobashigawa J, Miller L, Saltzberg M, Konstam M, Portner PM, Kormos R; Board of Directors of the International Society for Heart and Lung Transplantation. Deng MC, et al. Among authors: saltzberg m. J Heart Lung Transplant. 2003 Apr;22(4):365-9. doi: 10.1016/s1053-2498(03)00073-1. J Heart Lung Transplant. 2003. PMID: 12681414 No abstract available.
Deciding which drugs get onto the formulary: a value-based approach.
Seigfried RJ, Corbo T, Saltzberg MT, Reitz J, Bennett DA. Seigfried RJ, et al. Among authors: saltzberg mt. Value Health. 2013 Jul-Aug;16(5):901-6. doi: 10.1016/j.jval.2013.03.1623. Epub 2013 May 15. Value Health. 2013. PMID: 23947985 Free article.
37 results